M R Middleton - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M R Middleton

Showing results (1-10 of 54) with videos related to

Pageof 6

Sort By:

Journal of Adolescence|March 1, 1985

The Family Functioning in Adolescence Questionnaire: a measure of psychosocial family health during adolescenceR Roelofse, M R Middleton

Expert Review of Anticancer Therapy|July 13, 2002

Temozolomide: a novel oral alkylating agentS J Danson, M R Middleton

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014

A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stageJ M Findlay, M R Middleton, I Tomlinson

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000

Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanomaB E Hillner, S Agarwala, M R Middleton

Critical Reviews in Oncology/Hematology|February 19, 2005

Temozolomide in the treatment of solid tumours: current results and rationale for dosing/schedulingM J Payne, S E Pratap, M R Middleton

Cancer Chemotherapy and Pharmacology|January 27, 2000

Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenograftsM R Middleton, J Kelly, S Goodger, et al.

International Journal of Cancer|October 31, 2000

O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II studyM R Middleton, S M Lee, A Arance, et al.

European Radiology|September 8, 2010

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancerR S Gillies, M R Middleton, N D Maynard, et al.

Journal of Skin Cancer|October 29, 2013

Melanoma in buckinghamshire: data from the inception of the skin cancer multidisciplinary teamJ J Cubitt, A A Khan, E Royston, et al.

British Journal of Cancer|March 29, 2000

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanomaM R Middleton, P Lorigan, J Owen, et al.

Pageof 6

Search research articles

Showing results (1-10 of 54) with videos related to

Sort By:

Pageof 6

Journal of Adolescence|March 1, 1985

The Family Functioning in Adolescence Questionnaire: a measure of psychosocial family health during adolescenceR Roelofse, M R Middleton

Expert Review of Anticancer Therapy|July 13, 2002

Temozolomide: a novel oral alkylating agentS J Danson, M R Middleton

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014

A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stageJ M Findlay, M R Middleton, I Tomlinson

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000

Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanomaB E Hillner, S Agarwala, M R Middleton

Critical Reviews in Oncology/Hematology|February 19, 2005

Temozolomide in the treatment of solid tumours: current results and rationale for dosing/schedulingM J Payne, S E Pratap, M R Middleton

Cancer Chemotherapy and Pharmacology|January 27, 2000

Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenograftsM R Middleton, J Kelly, S Goodger, et al.

International Journal of Cancer|October 31, 2000

O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II studyM R Middleton, S M Lee, A Arance, et al.

European Radiology|September 8, 2010

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancerR S Gillies, M R Middleton, N D Maynard, et al.

Journal of Skin Cancer|October 29, 2013

Melanoma in buckinghamshire: data from the inception of the skin cancer multidisciplinary teamJ J Cubitt, A A Khan, E Royston, et al.

British Journal of Cancer|March 29, 2000

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanomaM R Middleton, P Lorigan, J Owen, et al.

Pageof 6